Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Pradere

Showing results (321-330 of 412) with videos related to

Pageof 42
Sort By:
Future Oncology (London, England)|April 27, 2026
Mitomycin for intravesical treatment of low-grade intermediate-risk non-muscle invasive bladder cancerLudovica Cella, Alessio Finocchiaro, Aleksander Ślusarczyk, et al.
Journal of Cancer Research and Clinical Oncology|January 8, 2022
Prognostic value of hepatocyte growth factor for muscle-invasive bladder cancerSatoshi Katayama, Victor M Schuettfort, Benjamin Pradere, et al.
Clinical Genitourinary Cancer|June 13, 2025
Prognostic Implications of Patients With Clinically Node Positive Bladder Cancer Undergoing Radical CystectomyPietro Scilipoti, Marco Moschini, Paolo Zaurito, et al.
World Journal of Urology|November 6, 2024
The role of re-transurethral resection of bladder tumor in patients with TaHG non muscle invasive bladder cancerPietro Scilipoti, Marco Moschini, Mario de Angelis, et al.
European Urology Oncology|January 1, 2026
Perioperative and Oncological Outcomes of Distal Ureterectomy for Upper Tract Urothelial Carcinoma (UTUC): A Multicentre Study from the European Association of Urology Non-muscle-invasive Bladder Cancer/UTUC Guidelines Panels with a Focus on Survival Free from Ipsilateral UTUC RecurrenceFrancesco Soria, Frederik Liedberg, Elin Stahl, et al.
European Urology|March 21, 2025
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: Summary of the 2025 UpdateAlexandra Masson-Lecomte, Alison Birtle, Benjamin Pradere, et al.
Arab Journal of Urology|January 5, 2024
Positive family history as a predictor for disease outcomes after radical prostatectomy for nonmetastatic prostate cancerPawel Rajwa, Fahad Quhal, David D'Andrea, et al.
Frontiers in Surgery|December 10, 2021
Intravesical Chemohyperthermia vs. Bacillus Calmette-Guerin Instillation for Intermediate- and High-Risk Non-muscle Invasive Bladder Cancer: A Systematic Review and Meta-AnalysisHongda Zhao, Vinson Wai-Shun Chan, Daniele Castellani, et al.
European Urology|March 26, 2023
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2023 UpdateMorgan Rouprêt, Thomas Seisen, Alison J Birtle, et al.
European Urology Oncology|June 20, 2024
The Role of Mitomycin C in Intermediate-risk Non-muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysisPietro Scilipoti, Aleksander Ślusarczyk, Mario de Angelis, et al.
Pageof 42

Showing results (321-330 of 412) with videos related to

Sort By:
Pageof 42
Future Oncology (London, England)|April 27, 2026
Mitomycin for intravesical treatment of low-grade intermediate-risk non-muscle invasive bladder cancerLudovica Cella, Alessio Finocchiaro, Aleksander Ślusarczyk, et al.
Journal of Cancer Research and Clinical Oncology|January 8, 2022
Prognostic value of hepatocyte growth factor for muscle-invasive bladder cancerSatoshi Katayama, Victor M Schuettfort, Benjamin Pradere, et al.
Clinical Genitourinary Cancer|June 13, 2025
Prognostic Implications of Patients With Clinically Node Positive Bladder Cancer Undergoing Radical CystectomyPietro Scilipoti, Marco Moschini, Paolo Zaurito, et al.
World Journal of Urology|November 6, 2024
The role of re-transurethral resection of bladder tumor in patients with TaHG non muscle invasive bladder cancerPietro Scilipoti, Marco Moschini, Mario de Angelis, et al.
European Urology Oncology|January 1, 2026
Perioperative and Oncological Outcomes of Distal Ureterectomy for Upper Tract Urothelial Carcinoma (UTUC): A Multicentre Study from the European Association of Urology Non-muscle-invasive Bladder Cancer/UTUC Guidelines Panels with a Focus on Survival Free from Ipsilateral UTUC RecurrenceFrancesco Soria, Frederik Liedberg, Elin Stahl, et al.
European Urology|March 21, 2025
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: Summary of the 2025 UpdateAlexandra Masson-Lecomte, Alison Birtle, Benjamin Pradere, et al.
Arab Journal of Urology|January 5, 2024
Positive family history as a predictor for disease outcomes after radical prostatectomy for nonmetastatic prostate cancerPawel Rajwa, Fahad Quhal, David D'Andrea, et al.
Frontiers in Surgery|December 10, 2021
Intravesical Chemohyperthermia vs. Bacillus Calmette-Guerin Instillation for Intermediate- and High-Risk Non-muscle Invasive Bladder Cancer: A Systematic Review and Meta-AnalysisHongda Zhao, Vinson Wai-Shun Chan, Daniele Castellani, et al.
European Urology|March 26, 2023
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2023 UpdateMorgan Rouprêt, Thomas Seisen, Alison J Birtle, et al.
European Urology Oncology|June 20, 2024
The Role of Mitomycin C in Intermediate-risk Non-muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysisPietro Scilipoti, Aleksander Ślusarczyk, Mario de Angelis, et al.
Pageof 42